Veradermics, Incorporated(MANE)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | CHILDS JOHN W Director | Purchase | +294,117 | +100.00%294,117 | $17.00 | $4,999,989 | View SEC filing | |
| 2026-02-09 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +282,674 | -85.20%520,453 | $37.30 | $10,542,478 | View SEC filing | |
| 2026-02-05 | Coric Vlad Director | Purchase | +117,646 | +18.07%768,735 | $17.00 | $1,999,982 | View SEC filing | |
| 2026-02-05 | CHILDS JOHN W Director | Purchase | +294,117 | +15.42%2,202,006 | $17.00 | $4,999,989 | View SEC filing | |
| 2026-02-05 | Longitude Venture Partners V, L.P. 10% Owner | Purchase | +1,075,000 | -14.71%2,053,474 | $17.00 | $18,275,000 | View SEC filing | |
| 2026-02-05 | ENRIGHT PATRICK G Director, 10% Owner | Purchase | +1,075,000 | +30.04%4,653,873 | $17.00 | $18,275,000 | View SEC filing |
1-6 of 6